BNGO
Bionano Genomics IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$12.76M
P/E Ratio
—
EPS
$-4.85
Beta
1.60
52W High
$5.50
52W Low
$1.06
50-Day MA
$1.19
200-Day MA
$2.11
Dividend Yield
—
Profit Margin
-92.60%
Forward P/E
—
PEG Ratio
—
About Bionano Genomics Inc
Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $28.51M |
| Gross Profit (TTM) | $13.19M |
| EBITDA | $-23.81M |
| Operating Margin | -107.40% |
| Return on Equity | -66.10% |
| Return on Assets | -27.70% |
| Revenue/Share (TTM) | $5.24 |
| Book Value | $4.14 |
| Price-to-Book | 0.30 |
| Price-to-Sales (TTM) | 0.45 |
| EV/Revenue | 0.0297 |
| EV/EBITDA | -0.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.60% |
| Shares Outstanding | $11.09M |
| Float | $9.96M |
| % Insiders | 7.66% |
| % Institutions | 10.60% |
Analyst Ratings
Consensus ($5.50 target)
1
Strong Buy1
BuyData last updated: 4/7/2026